Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
26 March 2021
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on diagnostic products addressing Hepatitis B and C Virus infections. Detailed information about the review process and submission requirements can be found in the document below.
Deadline for submission of an Expression of Interest is 25 May 2021. The results of the product evaluations are expected to be released in Q3 2021.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.